AcouSort AB genomför fullt säkerställd företrädesemission av units om cirka 40 MSEK
RegulatoryStyrelsen i AcouSort AB (publ) (“AcouSort” eller “Bolaget”) har idag, med stöd av årsstämmans bemyndigande, beslutat att genomföra en nyemission av högst 1 886 040 units bestående av aktier och
Read MoreAcouSort Interim Report Q2 2021
RegulatoryToday, August 25 2021, AcouSort is releasing its InterimReport for Q2, 2021. The report is in both Swedish and English. Read the full report here.
Read MoreMartin Olin becomes CEO of Norwegian BerGenBio – continues as chairman for AcouSort
AcouSort’s Chairman of the Board, Martin Olin, has been appointed CEO of the Norwegian biotechnology company BerGenBio ASA. Martin Olin will take up his new position on September 8 this
Read MoreAcouSort sells AcouWash system to Japanese distributor
AcouSort has sold an AcouWash system to its Japanese distributor Physio-Tech. Physio-Tech has over the last year worked intensively with introducing AcouSort’s bench-top systems to the Japanese market. Since the
Read MoreFirst collaboration phase with Belgian diagnostics company finalized
AcouSort has finalized the first phase of the previously announced collaboration project with a Belgian diagnostics company that develops innovative products for point-of-care testing. AcouSort has over the past months
Read MoreAcouSort reaches milestone for AcouPlasma Optical
The development process of AcouPlasma Optical has now reached an important milestone. The project has reached “Design freeze”, meaning that the final product design is finished. Read full pressrelease in
Read MoreAcouSort Interim Report Q1 2021
Today, May 26 2021, AcouSort is releasing its InterimReport for Q1, 2021. The report is in both Swedish and English. Read the full report here
Read MorePromising results in AcouSort’s latest feasibility study with Instrumentation Laboratory
AcouSort has finalized the recent feasibility project with Instrumentation Laboratory (IL) concerning generation of blood plasma aiming to expand the use of AcouSort’s technology in additional IL product lines. The
Read MoreAcouSort and Pharmacolog sign letter of intent to investigate integration of AcouSort’s blood separation technology
AcouSort AB and Uppsala-based Pharmacolog AB has signed a letter of intent concerning a long-term collaboration focused on investigating the potential of integrating AcouSort’s technology in Pharmacolog’s products. The aim
Read MoreCommuniqué from the Annual General Meeting of AcouSort AB (publ)
RegulatoryToday, April 28, 2021, the Annual General Meeting of AcouSort AB (publ) was held. Below is a summary of the decisions made. All decisions were made by the required majority.
Read More